Setshaba has always been committed to being at the forefront of prevailing health related research, and COVID-19 has been no exception.
We are one of three sites conducting the first vaccine trial for COVID-19 in South Africa: South African Ox1Cov-19 Vaccine VIDA-Trial.
We are currently recruiting participants for this study and are expecting to commence more research in this area within the near future.
We are keen to make an impactful contribution towards the global efforts in understanding, containing and preventing this novel virus.
On site adaptations:
We have adapted our site operational processes and workflows, to incorporate all recommended non-pharmaceutical interventions into our environment, including social distancing, regular hand washing and sanitizing and use of appropriate personal protective equipment.
We have extended our participant waiting areas to facilitate sufficient physical distancing between individuals.
We have conducted training for staff on the effective use of personal protective equipment (PPE) and are making use of visible and regular messaging to ensure there are consistent reminders to adhere to the measures in place.
We recognise that we are not alone in our efforts towards this disease, and that “Together We Can” achieve a lot more.
In this spirit, we have supported local clinics within the Soshanguve area in their efforts to manage this pandemic, by providing equipment and PPE to the clinics as well as offering some human resource support during the initial period of constraint. Some pictures of our efforts are included on our gallery page.